The Human Nup107-160 Nuclear Pore Subcomplex Contributes to Proper Kinetochore Functions
Overview
Molecular Biology
Authors
Affiliations
We previously demonstrated that a fraction of the human Nup107-160 nuclear pore subcomplex is recruited to kinetochores at the onset of mitosis. However, the molecular determinants for its kinetochore targeting and the functional significance of this localization were not investigated. Here, we show that the Nup107-160 complex interacts with CENP-F, but that CENP-F only moderately contributes to its targeting to kinetochores. In addition, we show that the recruitment of the Nup107-160 complex to kinetochores mainly depends on the Ndc80 complex. We further demonstrate that efficient depletion of the Nup107-160 complex from kinetochores, achieved either by combining siRNAs targeting several of its subunits excluding Seh1, or by depleting Seh1 alone, induces a mitotic delay. Further analysis of Seh1-depleted cells revealed impaired chromosome congression, reduced kinetochore tension and kinetochore-microtubule attachment defects. Finally, we show that the presence of the Nup107-160 complex at kinetochores is required for the recruitment of Crm1 and RanGAP1-RanBP2 to these structures. Together, our data thus provide the first molecular clues underlying the function of the human Nup107-160 complex at kinetochores.
Larizza L, Colombo E Int J Mol Sci. 2024; 25(17).
PMID: 39273335 PMC: 11394955. DOI: 10.3390/ijms25179387.
Advances in the understanding of nuclear pore complexes in human diseases.
Li Y, Zhu J, Zhai F, Kong L, Li H, Jin X J Cancer Res Clin Oncol. 2024; 150(7):374.
PMID: 39080077 PMC: 11289042. DOI: 10.1007/s00432-024-05881-5.
The scaffold nucleoporins SAR1 and SAR3 are essential for proper meiotic progression in .
Fernandez-Jimenez N, Martinez-Garcia M, Varas J, Gil-Dones F, Santos J, Pradillo M Front Cell Dev Biol. 2023; 11:1285695.
PMID: 38111849 PMC: 10725928. DOI: 10.3389/fcell.2023.1285695.
Nuclear transport proteins: structure, function, and disease relevance.
Yang Y, Guo L, Chen L, Gong B, Jia D, Sun Q Signal Transduct Target Ther. 2023; 8(1):425.
PMID: 37945593 PMC: 10636164. DOI: 10.1038/s41392-023-01649-4.
Reconstructing disease dynamics for mechanistic insights and clinical benefit.
Frishberg A, Milman N, Alpert A, Spitzer H, Asani B, Schiefelbein J Nat Commun. 2023; 14(1):6840.
PMID: 37891175 PMC: 10611752. DOI: 10.1038/s41467-023-42354-8.